A blood glucose level of 54 mg/dL or less was reported in 26% of patients receiving the 7 mg tablets, 30% of patients receiving the 14 mg tablets, and 32% with placebo
While not yet tested specifically in Lyme patients, studies demonstrate its influence on inflammatory pathways and immune cell signaling
NAD+ restores mitochondrial energy production
It means the clinical evidence is building and that patients pursuing this path need a clinician who can assess their individual response, not just apply a template
But for me, after trying everything else, BPC-157 made the difference I had been searching for
BPC-157, short for Body Protection Compound-157, is a synthetic peptide consisting of 15 amino acids in a specific sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val